Company Search:
Advanced Search
Sponsored Links
Protalix Biotherapeutics Inc Company Snapshot
Protalix Biotherapeutics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protalix Biotherapeutics Inc with three other companies in this sector in UNITED STATES : Twist Bioscience Corp (2019 sales of $54.39 million of which 40% was Industrial chemicals), Apollo Endosurgery Inc ($50.71 million of which 56% was Endo bariatric-ESS), and PDL Biopharma, Inc. ($54.76 million of which 101% was Pharmaceutical).

Sales Analysis. During the year ended December of 2019, sales at Protalix Biotherapeutics Inc were $54.69 million. This is an increase of 59.7% versus 2018, when the company's sales were $34.24 million. This was the fourth straight year of sales growth at Protalix Biotherapeutics Inc.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Protalix Biotherapeutics Inc
  Stock Performance Chart for Protalix Biotherapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 3.65
(Figures in U.S. Dollars)
1 Week 8.0%   13 Weeks -3.9%  
4 Weeks -12.7%   52 Weeks 82.5%  
Protalix Biotherapeutics Inc Key Data:
  Ticker: PLX Country: Israel
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 54,693,000
(Year Ending Jan 2020).
Employees: 196
  Currency: U.S. Dollars Market Cap: 118,415,621
  Fiscal Yr Ends: December Shares Outstanding: 32,442,636
  Share Type: Common Closely Held Shares: 10,742,569
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.